Moleculin Biotech, Inc. Retained Earnings
Moleculin Biotech, Inc. (MBRX) had Retained Earnings of -$226.48 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-13
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$226.48M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$218.85M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$206.00M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$221.56M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$226.48M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | -$218.85M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | -$206.00M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | -$221.56M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | -$196.16M 10-Q · filed 2025-11-13 | -$167.44M 10-Q · filed 2025-08-12 |
| 2025-03-31 | -$178.35M 10-Q · filed 2025-11-13 | -$159.80M 10-Q · filed 2025-05-13 |
| 2024-12-31 | -$172.44M 10-K · filed 2026-03-18 | -$153.37M 10-K · filed 2025-03-21 |
| 2024-09-30 | -$151.49M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | -$140.89M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | -$136.57M 10-Q · filed 2024-05-10 | |
| 2024-01-01 | -$146.40M 10-Q · filed 2026-08-13 | |
| 2023-12-31 | -$131.60M 10-K · filed 2025-03-21 | |
| 2023-09-30 | -$121.33M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | -$115.73M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | -$109.75M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | -$101.83M 10-K · filed 2024-03-22 | |
| 2022-09-30 | -$95.06M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | -$86.45M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | -$79.68M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | -$72.81M 10-K · filed 2023-03-22 | |
| 2021-09-30 | -$69.98M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | -$65.61M 10-Q · filed 2021-08-11 | |
| 2021-03-31 | -$61.36M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | -$56.92M 10-K · filed 2022-03-24 | |
| 2020-09-30 | -$54.28M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | -$50.88M 10-Q · filed 2020-08-12 | |
| 2020-03-31 | -$40.77M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | -$39.56M 10-K · filed 2021-03-24 | |
| 2019-09-30 | -$35.76M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | -$31.62M 10-Q · filed 2019-08-16 | |
| 2019-03-31 | -$30.40M 10-Q · filed 2019-05-13 | |
| 2018-12-31 | -$26.36M 10-K · filed 2020-03-19 | |
| 2018-09-30 | -$23.57M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | -$21.53M 10-Q · filed 2018-08-10 | |
| 2018-03-31 | -$16.41M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | -$14.48M 10-K · filed 2019-02-21 | |
| 2017-09-30 | -$11.29M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | -$8.43M 10-Q · filed 2017-08-11 | |
| 2017-03-31 | -$5.00M 10-Q · filed 2017-05-12 | |
| 2016-12-31 | -$4.67M 10-K · filed 2018-03-28 | -$4.67M 10-K · filed 2017-04-03 |
| 2016-09-30 | -$3.25M 10-Q · filed 2016-11-21 | |
| 2016-06-30 | -$1.82M 10-Q · filed 2016-11-21 | -$2.08M 10-Q · filed 2016-08-15 |
| 2016-03-31 | -$1.08M 10-Q · filed 2016-06-16 | |
| 2015-12-31 | -$748.36K 10-K · filed 2017-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |